Annika Carin M. Espander Jansson
Directeur/Membre du Conseil chez LIFCO AB
Fortune : 245 994 $ au 30/04/2024
Profil
Annika Carin M.
Espander Jansson is the founder of Asperia AB, which was founded in 2013.
She is currently an Independent Director at Lifco AB and a Director at Sjöbergstiftelsen.
Her former positions include Chairman at Svenska Handelsbanken AB (Luxembourg), Head- Private Banking at Svenska Handelsbanken AB, and Managing Partner at Catella Healthcare AB.
She has also held various director positions at Probi AB, Elekta AB, Biotage AB, Stille AB, Millicore AB, Attana AB, Symphogen A, Takara Bio Europe AB, DuoCort AB, Esperio AB, Svenska Handelsbanken AB (Broker), and Skandinaviska Enskilda Banken AB (Broker).
Dr. Espander Jansson has an undergraduate degree from the University of Michigan and undergraduate and MBA degrees from the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIFCO AB CLASS B
0,00% | 31/12/2023 | 10 000 ( 0,00% ) | 245 994 $ | 30/04/2024 |
Postes actifs de Annika Carin M. Espander Jansson
| Sociétés | Poste | Début |
|---|---|---|
| LIFCO AB | Directeur/Membre du Conseil | 01/01/2016 |
| Sjöbergstiftelsen | Directeur/Membre du Conseil | - |
| Asperia AB | Fondateur | 01/06/2013 |
Anciens postes connus de Annika Carin M. Espander Jansson
| Sociétés | Poste | Fin |
|---|---|---|
| Svenska Handelsbanken AB (Luxembourg) | Président | 02/01/2013 |
Millicore AB
 Millicore AB Electronic Equipment/InstrumentsElectronic Technology Millicore AB provides medical technology solutions. It is engaged in the business of development and commercialization of MEMS-based digital disposable products for the healthcare industry. The company was founded in 2003 and is headquartered in Stockholm, Sweden | Directeur/Membre du Conseil | 03/03/2011 |
Catella Healthcare AB
 Catella Healthcare AB Investment ManagersFinance Part of Catella AB, Catella Healthcare AB is an alternative investment manager. The company is based in Stockholm, Sweden. | Corporate Officer/Principal | 01/01/2008 |
Svenska Handelsbanken AB (Broker)
 Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Analyst-Equity | 09/11/2004 |
| Svenska Handelsbanken AB (Broker Denmark) | Corporate Officer/Principal | 01/01/2004 |
Formation de Annika Carin M. Espander Jansson
| University of Michigan | Undergraduate Degree |
| University of Uppsala | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| ATTANA AB | Health Services |
| BIOTAGE AB | Health Technology |
| STILLE AB | Health Technology |
| PROBI AB | Health Technology |
| ELEKTA AB | Health Technology |
| LIFCO AB | Producer Manufacturing |
| SVENSKA HANDELSBANKEN AB | Finance |
| Entreprise privées | 14 |
|---|---|
Catella Healthcare AB
Catella Healthcare AB Investment ManagersFinance Part of Catella AB, Catella Healthcare AB is an alternative investment manager. The company is based in Stockholm, Sweden. | Finance |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Skandinaviska Enskilda Banken AB (Broker)
 Skandinaviska Enskilda Banken AB (Broker) Investment Banks/BrokersFinance Skandinaviska Enskilda Banken AB (Broker) (SEB-Broker) is the broker/dealer division of Skandinaviska Enskilda Banken AB (STO: SEB-A; OTCMKTS: SVKEF), a financial group headquartered in Stockholm, Sweden. Founded in 1856, SEB-Broker provides trading and executions services to their clients. | Finance |
Millicore AB
Millicore AB Electronic Equipment/InstrumentsElectronic Technology Millicore AB provides medical technology solutions. It is engaged in the business of development and commercialization of MEMS-based digital disposable products for the healthcare industry. The company was founded in 2003 and is headquartered in Stockholm, Sweden | Electronic Technology |
Svenska Handelsbanken AB (Broker)
Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Finance |
DuoCort AB
 DuoCort AB Pharmaceuticals: MajorHealth Technology DuoCort AB manufactures pharmaceutical products. The company is based in Helsingborg, Sweden. The Swedish company was founded by Thomas Hedner. | Health Technology |
| Svenska Handelsbanken AB (Broker Denmark) | Finance |
| Kabi Pharmacia | |
| Svenska Handelsbanken AB (Luxembourg) | Finance |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
| Pharmacia Peptide Hormones | |
| Esperio AB | |
| Asperia AB | |
| Sjöbergstiftelsen | Miscellaneous |